Drug intelligence / Profile preview

Physiogel A.I.

Development stage
Unknown
Lead developer
Stiefel
Modality
Small Molecules
Administration
Topical
01

Overview

Physiogel A.I. (also known as Calming Relief A.I.) is a hypoallergenic topical skincare product developed by Stiefel (a GSK company) for the treatment of dry, irritated, and reactive skin conditions such as atopic dermatitis and xerosis. Its primary active ingredient is palmidrol (palmitamide MEA), an endogenous fatty acid amide that acts as an anti-inflammatory and anti-pruritic agent by modulating the endocannabinoid system, specifically through the activation of PPAR-alpha. The formulation also incorporates a BioMimic complex containing ceramides (such as ceramide 3), squalane, and lecithin to repair and strengthen the skin's moisture barrier. It is marketed as a preservative-free and fragrance-free cream or lotion suitable for sensitive skin in both adults and children. In 2020, the Physiogel brand was acquired by LG Household & Health Care from GSK.

Brand names
Physiogel A.I.Calming Relief A.I.Physiogel A.I. Corpo
Other names
palmitamide MEAN-palmitoylethanolamidePEApalmidrol
02

Targets

Cer (Ceramide)PPARA (Peroxisome proliferator-activated receptor alpha)

Beyond the preview

Go deeper on Physiogel A.I..

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Physiogel A.I..

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call